1. Home
  2. Browse
  3. Cardiology
  4. Dyslipidemia

Dyslipidemia

301 - 315 of 318 Results
Sort Results:
Guideline: Third Report of the NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults and Implications of Recent Clinical Trials for the NCEP Guidelines February 2008
Guideline: Third Report of the NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults and Implications of Recent Clinical Trials for the NCEP Guidelines (2001, Update: 2004, Modified 2008) February 2008
Guideline: Third Report of the NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults and Implications of Recent Clinical Trials for the NCEP Guidelines (2001, Updated 2004, Modified 2008) January 2007
Commentary: Intensive LDL Reduction: What is the Evidence? January 2007
Commentary: Niacin Use: An Update December 2005
Article: whether patients can use other niacin products in place of Niaspan December 2005
Other: New Drug: Lovaza (formerly Omacor) (Omega-3 Acid Ethyl Esters) October 2005
Article: Omacor, the first PRESCRIPTION omega-3 fatty acid product October 2005
Other: FDA Public Health Advisory on Crestor (rosuvastatin) April 2005
Commentary: An Update on Potential New Uses for Statins July 2004
Guideline: American College of Physicians Clinical Practice Guideline on Lipid Control in the Management of Type 2 Diabetes Mellitus (2004) June 2004
Commentary: Lipid Control in Diabetes: Review of Clinical Practice Guidelines June 2004
Guideline: ADA Position Statement on Dyslipidemia Management in Adults with Diabetes (2004) June 2004
Article: more emphasis on reducing "trans fats" in foods August 2003
Article: Pravigard PAC, the first statin and aspirin combo August 2003